Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gianluigi Petrone
Pembrolizumab as First-Line Treatment for Metastatic Uveal Melanoma
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
The Impact of FNAC in the Management of Salivary Gland Lesions: Institutional Experiences Leading to a Risk-Based Classification Scheme
Cancer cytopathology
Cancer Research
Oncology
Related publications
Pembrolizumab-Induced Sarcoid-Like Reactions During Treatment of Metastatic Melanoma
Radiology
Nuclear Medicine
Radiology
Imaging
Nanoparticles for Uveal Melanoma Treatment
Cutaneous CD56 + T-Cell Lymphoma Developing During Pembrolizumab Treatment for Metastatic Melanoma
JAAD Case Reports
Dermatology
Nestin Expression in Primary and Metastatic Uveal Melanoma - Possible Biomarker for High-Risk Uveal Melanoma
Acta Ophthalmologica
Medicine
Ophthalmology
Pcn34 - Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-Squamous NSCLC – A Network Meta-Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Verification of EZH2 as a Druggable Target in Metastatic Uveal Melanoma
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Cost Effectiveness of PD-L1-Based Test-And-Treat Strategy With Pembrolizumab as the First-Line Treatment for Metastatic NSCLC in Hong Kong
PharmacoEconomics - Open
Health Policy
Pharmacology
Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Nonsquamous Non-Small-Cell Lung Cancer: A Network Meta-Analysis
Immunotherapy
Oncology
Allergy
Immunology
iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors
PLoS ONE
Multidisciplinary
